Autoimmune gastrointestinal dysmotility following SARS-CoV-2 infection successfully treated with intravenous immunoglobulin정맥 면역글로불린으로 성공적으로 치료된 SARS-CoV-2 감염 후 자가면역 위장 운동 장애Case Reports Published on 2022-07-012022-09-12 Journal: Neurogastroenterology and motility : the official [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] antibody Autoimmune autoimmune dysautonomia autoimmune gastrointestinal dysmotility (AGID) autonomic baseline bowel elevated ganglionic Gastrointestinal impairment intractable Intravenous immunoglobulin IVIG nausea over post-viral. reflected required SARS-CoV-2 SARS-COV-2 infection Sweat Symptom the patient treatable treated Treatment viral infection [DOI] 10.1111/nmo.14314 PMC 바로가기 [Article Type] Case Reports